 Ultragenyx Pharmaceutical Inc. - 企業プロファイルおよびSWOT分析Ultragenyx Pharmaceutical Inc. - Company Profile and SWOT Analysis Ultragenyx Pharmaceutical Inc. - 企業プロファイルおよびSWOT分析 概要 Ultragenyx Pharmaceutical Inc. - 企業プロファイルおよびSWOT分析は、包括的な企業データおよび情報源です。本レポートは、同社... もっと見る
サマリーUltragenyx Pharmaceutical Inc. - 企業プロファイルおよびSWOT分析概要 Ultragenyx Pharmaceutical Inc. - 企業プロファイルおよびSWOT分析は、包括的な企業データおよび情報源です。本レポートは、同社の組織構造、事業運営、SWOT分析、製品・サービス提供、および企業活動を網羅し、同社の360度の全体像を提供します。 主なハイライト Ultragenyx Pharmaceutical Inc.(Ultragenyx)は、臨床段階のバイオ医薬品企業です。同社は、希少疾患および超希少疾患の治療を目的とした新規製品の発見、取得、開発、および商業化を行っています。同社の販売中の製品には、X連鎖性低リン血症(XLH)および腫瘍性骨軟化症(TIO)向けのCrysvita、ムコ多糖症VII型(MPS VII、スライ症候群)治療向けのMepsevii、長鎖脂肪酸酸化障害(LC-FAOD)治療向けのDojolviがあります。また、オルニチントランスカルバミラーゼ(OTC)欠損症治療向けのDTX301、グリコーゲン貯蔵病1a型(GSDIa)治療向けのDTX401という2つのパイプライン製品も開発中です。Ultragenyxは子会社を通じて、英国、スイス、米国、ドイツ、ブラジル、アルゼンチン、オランダ、フランス、コロンビア、カナダ、メキシコで事業を展開しています。同社は米国カリフォルニア州ノバトに本社を置いています。 本レポートの対象範囲 - 事業戦略および競合インテリジェンスに必要なUltragenyx Pharmaceutical Inc.に関する詳細情報 - SWOT分析の形式による、Ultragenyx Pharmaceutical Inc.に影響を与える主要な内部要因および外部要因の分析 - 主要事業セグメントの内訳と検証を含む、Ultragenyx Pharmaceutical Inc.のビジネスモデルの詳細な分析 - Ultragenyx Pharmaceutical Inc.のM&A(合併・買収)、戦略的パートナーシップおよび提携、資金調達、プライベートエクイティ取引、財務・法務アドバイザーに関するインテリジェンス - 事業拡大、再編、契約獲得など、Ultragenyx Pharmaceutical Inc.に関するニュース - 重要なデータや主要トレンドを示す、分かりやすい図表・グラフを豊富に掲載 本レポートを購入する理由 - Ultragenyx Pharmaceutical Inc.およびその戦略に影響を与える要因について理解を深めることができます。 - 同社の戦略的取り組みや最新の企業ニュース・動向を追跡できます。 - Ultragenyx Pharmaceutical Inc.を将来的なパートナー、ベンダー、またはサプライヤーとして評価できます。 - 顧客企業のビジネスをより深く理解することで、営業活動を支援します。 - Ultragenyx Pharmaceutical Inc.の事業構造、戦略、今後の見通しについて最新情報を把握できます。 目次Table of ContentsCompany Snapshot Ultragenyx Pharmaceutical Inc.: Company Overview Ultragenyx Pharmaceutical Inc.: Overview and Key Facts Ultragenyx Pharmaceutical Inc.: Overview Ultragenyx Pharmaceutical Inc.: Key Facts Ultragenyx Pharmaceutical Inc.: Key Employees Ultragenyx Pharmaceutical Inc.: Key Employee Biographies Ultragenyx Pharmaceutical Inc.: Major Products and Services Ultragenyx Pharmaceutical Inc.: Management Statement Ultragenyx Pharmaceutical Inc.: Key Competitors Ultragenyx Pharmaceutical Inc.: Company Analysis Ultragenyx Pharmaceutical Inc.: Business Description Ultragenyx Pharmaceutical Inc.: SWOT Analysis Ultragenyx Pharmaceutical Inc.: SWOT Overview Ultragenyx Pharmaceutical Inc.: Strengths Ultragenyx Pharmaceutical Inc.: Weaknesses Ultragenyx Pharmaceutical Inc.: Opportunities Ultragenyx Pharmaceutical Inc.: Threats Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity Ultragenyx Pharmaceutical Inc.: Financial Deals Overview Ultragenyx Pharmaceutical Inc.: Targets and Partners Ultragenyx Pharmaceutical Inc.: Top Deals 2022 - 2026YTD* Ultragenyx Pharmaceutical Inc.: Advisors Ultragenyx Pharmaceutical Inc.: Top Legal Advisors Ultragenyx Pharmaceutical Inc.: Top Financial Advisors Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions Ultragenyx Pharmaceutical Inc.: Corporate Venturing Ultragenyx Pharmaceutical Inc.: Capital Raising Ultragenyx Pharmaceutical Inc.: Partnership Ultragenyx Pharmaceutical Inc.: Divestments Ultragenyx Pharmaceutical Inc.: Recent Developments Ultragenyx Pharmaceutical Inc.: News and Events Summary Ultragenyx Pharmaceutical Inc.: Business Expansion Ultragenyx Pharmaceutical Inc.: Corporate Governance Ultragenyx Pharmaceutical Inc.: Financial Performance Ultragenyx Pharmaceutical Inc.: Market Developments Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events Ultragenyx Pharmaceutical Inc.: Research & Development Ultragenyx Pharmaceutical Inc.: Strategy and Operations Appendix Contact Us Methodology About MarketLine 図表リストList of TablesTable 1: Ultragenyx Pharmaceutical Inc.: Key Facts Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees Table 3: Ultragenyx Pharmaceutical Inc.: Key Competitors Table 4: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*) Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Table 6: Ultragenyx Pharmaceutical Inc.: Targets and Partners Table 7: Ultragenyx Pharmaceutical Inc.: Top Deals 2022 - 2026YTD* Table 8: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m) Table 9: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m) Table 10: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2022 - YTD*2026) Table 11: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2022 - YTD*2026) Table 12: Ultragenyx Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026) Table 13: Ultragenyx Pharmaceutical Inc.: Corporate Venturing by Geography (2022 - YTD*2026) Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2022 - YTD*2026) Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary Table 20: Ultragenyx Pharmaceutical Inc.: Business Expansion Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Governance Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and OperationsList of Figures Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*) Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2022 - YTD*2026) Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2022 - YTD*2026) Figure 5: Ultragenyx Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026) Figure 6: Ultragenyx Pharmaceutical Inc.: Corporate Venturing by Geography (2022 - YTD*2026) Figure 7: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Figure 8: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Figure 9: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Figure 10: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Figure 11: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
SummaryUltragenyx Pharmaceutical Inc. - Company Profile and SWOT AnalysisSummary Ultragenyx Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Ultragenyx Pharmaceutical Inc. (Ultragenyx) is a clinical-stage biopharmaceutical company. It is involved in the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company's marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for the treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products, including DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency, and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). Ultragenyx through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, the Netherlands, France, Colombia, Canada, and Mexico. The company is headquartered in Novato, California, the US Scope - Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis - An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments - Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Reasons to Buy - Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies. - Track strategic initiatives of the company and latest corporate news and actions. - Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier. - Support sales activities by understanding your customers' businesses better. - Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects. Table of ContentsTable of ContentsCompany Snapshot Ultragenyx Pharmaceutical Inc.: Company Overview Ultragenyx Pharmaceutical Inc.: Overview and Key Facts Ultragenyx Pharmaceutical Inc.: Overview Ultragenyx Pharmaceutical Inc.: Key Facts Ultragenyx Pharmaceutical Inc.: Key Employees Ultragenyx Pharmaceutical Inc.: Key Employee Biographies Ultragenyx Pharmaceutical Inc.: Major Products and Services Ultragenyx Pharmaceutical Inc.: Management Statement Ultragenyx Pharmaceutical Inc.: Key Competitors Ultragenyx Pharmaceutical Inc.: Company Analysis Ultragenyx Pharmaceutical Inc.: Business Description Ultragenyx Pharmaceutical Inc.: SWOT Analysis Ultragenyx Pharmaceutical Inc.: SWOT Overview Ultragenyx Pharmaceutical Inc.: Strengths Ultragenyx Pharmaceutical Inc.: Weaknesses Ultragenyx Pharmaceutical Inc.: Opportunities Ultragenyx Pharmaceutical Inc.: Threats Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity Ultragenyx Pharmaceutical Inc.: Financial Deals Overview Ultragenyx Pharmaceutical Inc.: Targets and Partners Ultragenyx Pharmaceutical Inc.: Top Deals 2022 - 2026YTD* Ultragenyx Pharmaceutical Inc.: Advisors Ultragenyx Pharmaceutical Inc.: Top Legal Advisors Ultragenyx Pharmaceutical Inc.: Top Financial Advisors Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions Ultragenyx Pharmaceutical Inc.: Corporate Venturing Ultragenyx Pharmaceutical Inc.: Capital Raising Ultragenyx Pharmaceutical Inc.: Partnership Ultragenyx Pharmaceutical Inc.: Divestments Ultragenyx Pharmaceutical Inc.: Recent Developments Ultragenyx Pharmaceutical Inc.: News and Events Summary Ultragenyx Pharmaceutical Inc.: Business Expansion Ultragenyx Pharmaceutical Inc.: Corporate Governance Ultragenyx Pharmaceutical Inc.: Financial Performance Ultragenyx Pharmaceutical Inc.: Market Developments Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events Ultragenyx Pharmaceutical Inc.: Research & Development Ultragenyx Pharmaceutical Inc.: Strategy and Operations Appendix Contact Us Methodology About MarketLine List of Tables/GraphsList of TablesTable 1: Ultragenyx Pharmaceutical Inc.: Key Facts Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees Table 3: Ultragenyx Pharmaceutical Inc.: Key Competitors Table 4: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*) Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Table 6: Ultragenyx Pharmaceutical Inc.: Targets and Partners Table 7: Ultragenyx Pharmaceutical Inc.: Top Deals 2022 - 2026YTD* Table 8: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m) Table 9: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m) Table 10: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2022 - YTD*2026) Table 11: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2022 - YTD*2026) Table 12: Ultragenyx Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026) Table 13: Ultragenyx Pharmaceutical Inc.: Corporate Venturing by Geography (2022 - YTD*2026) Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2022 - YTD*2026) Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary Table 20: Ultragenyx Pharmaceutical Inc.: Business Expansion Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Governance Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and OperationsList of Figures Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*) Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2022 - YTD*2026) Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2022 - YTD*2026) Figure 5: Ultragenyx Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026) Figure 6: Ultragenyx Pharmaceutical Inc.: Corporate Venturing by Geography (2022 - YTD*2026) Figure 7: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Figure 8: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Figure 9: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Figure 10: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Figure 11: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
MarketLine社の Pharmaceuticals and Healthcare分野 での最新刊レポート
本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート
よくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン（MarketLine）は、世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版しています。 マーケットライン（MarketLine）はGlobalDataの... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
